|
The main aim of Neuron Bio is to generate marketable biotechnological knowledge via the use of scientific research. Neuron Bio obtains its income from the sale and/or licensing of prospective pharmaceuticals, including neuroprotective nutraceuticals, and also from biotechnological services offered to pharmaceutical, chemical, agro-food and biofuel companies.
With the creation of Neuron Bio its directors made a public commitment to the responsible management of a modern company designed to be a worldwide reference within its sector.
Neuron Bio does not concentrate its activities solely on the development and marketing of its products and services, however; its management is fully aware that its conduct must be based upon a commitment to research, development and innovation within a context of social responsibility guided by ethical values, and thus has voluntarily undertaken a series of obligations and commitments that exceed the mere legal and ethical national and international obligations arising from the impact of the company’s activities upon its local social, working and environmental surroundings as well as human rights in general.
|
|